StonvexLoading…
StonvexStonvexStonvexCore line items from BBW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $529.83M | $375.32M | $252.64M | $128.40M |
Operating Income | $67.23M | $45.68M | $34.95M | $19.63M |
Net Income | $52.20M | $35.81M | $27.69M | $15.32M |
EPS (Diluted) | $3.99 | $2.73 | $2.11 | $1.17 |
Total Assets | $345.45M | $326.50M | $318.24M | $308.30M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $26.75M | $27.74M | $39.11M | $44.34M |
Free Cash Flow OCF − CapEx | $39.51M | $27.39M | $25.69M | $24.90M |
Shares Outstanding | 12.81M | 12.99M | 13.16M | 13.17M |